These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 6896

  • 1. Serotonin and lysergic acid diethylamide binding in rat brain membranes: relationship to postsynaptic serotonin receptors.
    Bennett JP, Snyder SH.
    Mol Pharmacol; 1976 May; 12(3):373-89. PubMed ID: 6896
    [No Abstract] [Full Text] [Related]

  • 2. High-affinity binding of (3H) 5-hydroxytryptamine to brain synaptosomal membranes: comparison with (3H) lysergic acid diethylamide binding.
    Fillion GM, Rousselle JC, Fillion MP, Beaudoin DM, Goiny MR, Deniau JM, Jacob JJ.
    Mol Pharmacol; 1978 Jan; 14(1):50-9. PubMed ID: 625289
    [No Abstract] [Full Text] [Related]

  • 3. [Serotonin and D-lysergic acid diethylamide receptors in the mammalian brain].
    Vlasova TI, Kirzon MV.
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1981 Jan; (5):5-16. PubMed ID: 6264979
    [No Abstract] [Full Text] [Related]

  • 4. 5-HT and LSD high affinity binding sites to brain synaptosomal membranes [proceedings].
    Fillion G, Fillion MP, Jacob J, Rousselle JC.
    Br J Pharmacol; 1976 Nov; 58(3):425P-426P. PubMed ID: 990612
    [No Abstract] [Full Text] [Related]

  • 5. Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol.
    Peroutka SJ, Snyder SH.
    Mol Pharmacol; 1979 Nov; 16(3):687-99. PubMed ID: 530254
    [No Abstract] [Full Text] [Related]

  • 6. Displacement of specific serotonin and lysergic acid diethylamide binding by Ergalgin, a new antiserotonin drug.
    Oelszner W.
    Acta Biol Med Ger; 1980 Nov; 39(8-9):897-901. PubMed ID: 7282219
    [Abstract] [Full Text] [Related]

  • 7. 5-Hydroxytryptamine binding to synaptic membranes from rat brain.
    Fillion G, Fillion MP, Spirakis C, Bahers JM, Jacob J.
    Life Sci; 1976 Jan 01; 18(1):65-74. PubMed ID: 2829
    [No Abstract] [Full Text] [Related]

  • 8. Stereospecificity of interaction of neuroleptic drugs with neurotransmitters and correlation with clinical potency.
    Enna SJ, Bennett JP, Burt DR, Creese I, Snyder SH.
    Nature; 1976 Sep 23; 263(5575):338-41. PubMed ID: 8733
    [No Abstract] [Full Text] [Related]

  • 9. [High affinity binding of 5-hydroxytryptamine to some membrane preparations from cattle brain. Relationship to lysergic acid diethylamide (LSD)].
    Fillion G, Fillion MP, Rousselle JC, Beaudoin D, Goiny M, Jacob J.
    C R Acad Hebd Seances Acad Sci D; 1977 Mar 14; 284(11):979-81. PubMed ID: 405135
    [Abstract] [Full Text] [Related]

  • 10. Stereospecific receptor sites for d-lysergic acid diethylamide in rat brain: effects of neurotransmitters, amine antagonists, and other psychotropic drugs.
    Lovell RA, Freedman DX.
    Mol Pharmacol; 1976 Jul 14; 12(4):620-30. PubMed ID: 8700
    [No Abstract] [Full Text] [Related]

  • 11. QSAR of agents involved in serotonin and LSD binding sites.
    Chan YL, Lien EJ, Shih JC.
    NIDA Res Monogr; 1978 Jul 14; (22):103-13. PubMed ID: 30904
    [No Abstract] [Full Text] [Related]

  • 12. [Action of LSD and 5-methoxy-N,N-dimethyltryptamine on the high affinity uptake of [3H]-serotonin by isolated rat brain synaptosomes].
    Uebelhack R, Franke L, Seidel K.
    Acta Biol Med Ger; 1978 Jul 14; 37(10):1611-4. PubMed ID: 752213
    [Abstract] [Full Text] [Related]

  • 13. Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide.
    Burris KD, Sanders-Bush E.
    Mol Pharmacol; 1992 Nov 14; 42(5):826-30. PubMed ID: 1359397
    [Abstract] [Full Text] [Related]

  • 14. Stereospecific binding of D-lysergic acid diethylamide (LSD) to brain membranes: relationship to serotonin receptors.
    Bennett JP, snyder SH.
    Brain Res; 1975 Sep 05; 94(3):523-44. PubMed ID: 239784
    [Abstract] [Full Text] [Related]

  • 15. [Relation between the binding of 3H-imipramine and the uptake of catecholamines in synaptosomal preparations of the rat brain after chronic treatment with imipramine].
    Dagonneau H, Fonlupt P, Pacheco H.
    C R Seances Soc Biol Fil; 1984 Sep 05; 178(1):38-44. PubMed ID: 6331605
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of neurotransmitter receptor binding by ergot derivatives.
    Hruska RE, Silbergeld EK.
    J Neurosci Res; 1981 Sep 05; 6(1):1-11. PubMed ID: 6111611
    [Abstract] [Full Text] [Related]

  • 17. Characterization of endogenous inhibitors of [3H]-imipramine binding and [3H]-serotonin uptake from rat serum.
    Angel I, Goldman ME, Skolnick P, Pisano JJ, Paul SM.
    Prog Clin Biol Res; 1985 Sep 05; 192():457-64. PubMed ID: 3001766
    [Abstract] [Full Text] [Related]

  • 18. The in vitro identification of dimethyltryptamine (DMT) in mammalian brain and its characterization as a possible endogenous neuroregulatory agent.
    Christian ST, Harrison R, Quayle E, Pagel J, Monti J.
    Biochem Med; 1977 Oct 05; 18(2):164-83. PubMed ID: 20877
    [No Abstract] [Full Text] [Related]

  • 19. Postsynaptic serotonin-sensitive adenylate cyclase in the central nervous system. II. Comparison with dopamine- and isoproterenol-sensitive adenylate cyclases in rat brain.
    Enjalbert A, Hamon M, Bourgoin S, Bockaert J.
    Mol Pharmacol; 1978 Jan 05; 14(1):11-23. PubMed ID: 24167
    [No Abstract] [Full Text] [Related]

  • 20. Serotonin receptors in the brain.
    Haigler HJ, Aghajanian GK.
    Fed Proc; 1977 Jul 05; 36(8):2159-64. PubMed ID: 326580
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.